TGF-β receptor signaling is critical for mucosal IgA responses

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3305-3309

  Borsutzky, Stefan ^a   Cazac, Balthazar B ^b   Roes, Jürgen ^b   Guzmán, Carlos A ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; LIPOPEPTIDE; MACROPHAGE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MUCOSA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 4344623276     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3305     Document Type: Article

References (56)

1. Underdown, B. J., and J. M. Schiff. 1986. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu. Rev. Immunol. 4:389.
2. Lamm, M. E. 1997. Interaction of antigens and antibodies at mucosal surfaces. Annu. Rev. Microbiol. 51:311.
3. Langford, T. D., M. P. Housley, M. Boes, J. Chen, M. F. Kagnoff, F. D. Gillin, and L. Eckmann. 2002. Central importance of immunoglobulin A in host defense against Giardia spp. Infect. Immun. 70:11.
4. Johansen, F. E., M. Pekna, I. N. Norderhaug, B. Haneberg, M. A. Hietala, P. Krajci, C. Betsholtz, and P. Brandtzaeg. 1999. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J. Exp. Med. 190:915.
5. Uren, T. K., F. E. Johansen, O. L. Wijburg, F. Koentgen, P. Brandtzaeg, and R. A. Strugnell. 2003. Role of the polymeric Ig receptor in mucosal B cell homeostasis. J. Immunol. 170:2531.
6. Kunimoto, D. Y., G. R. Harriman, and W. Strober. 1988. Regulation of IgA differentiation in CH12LX B cells by lymphokines. IL-4 induces membrane IgM-positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CH12LX cells to secrete IgA. J. Immunol. 141:713.
7. Murray, P., D. McKenzie, S. Swain, and M. Kagnoff. 1987. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J. Immunol. 139:2669.
8. Ramsay, A. J., S. Bao, K. W. Beagley, S. J. Dunsan, A. J. Husband, M. Kopf, K. I. Mattaei, I. A. Ramsahw, R. A. Strugnell, I. G. Young, and X. Tan. 1996. Cytokine gene knockout mice: lessons for mucosal B-cell development. In Essentials of Mucosal Immunology. M. F. Kagnoff, Kiyono, Hiroshi, eds. Academic, San Diego, p. 247.
9. Vajdy, M., M. H. Kosco-Vilbois, M. Kopf, G. Kohler, and N. Lycke, 1995. Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181:41.
10. Ramsay, A. J., A. J. Husband, I. A. Ramshaw, S. Bao, K. I. Matthaei, G. Koehler, and M. Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561.
11. Coffman, R. L., D. A. Lebman, and B. Shrader. 1989. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide- stimulated murine B lymphocytes. J. Exp. Med. 170:1039.
12. Sonoda, E., R. Matsumoto, Y. Hitoshi, T. Ishii, M. Sugimoto, S. Araki, A. Tominaga, N. Yamaguchi, and K. Takatsu. 1989. Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170:1415.
13. Kim, P. H., and M. F. Kagnoff. 1990. Transforming growth factor β1 increases IgA isotype switching at the clonal level. J. Immunol. 145:3773.
14. Shi, M. J., and J. Stavnezer. 1998. CBF α3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Ig α promoter. J. Immunol. 161:6751.
15. + B cells regardless of the method of B cell activation. J. Immunol. 148:3830.
16. Tokuyama, H., and Y. Tokuyama. 1997. Retinoic acid induces the expression of germ-line C α transcript mainly by a TGF-β-independent mechanism. Cell. Immunol. 176:14.
17. Tokuyama, H., and Y. Tokuyama. 1999. The regulatory effects of all-trans-retinoic acid on isotype switching: retinoic acid induces IgA switch rearrangement in cooperation with IL-5 and inhibits IgG1 switching. Cell. Immunol. 192:41.
18. Kimata, H., and M. Fujimoto. 1994. Vasoactive intestinal peptide specifically induces human IgA1 and IgA2 production. Eur. J. Immunol. 24:2262.
19. Kimata, H., and M. Fujimoto. 1995. Induction of IgA1 and IgA2 production in immature human fetal B cells and pre-B cells by vasoactive intestinal peptide. Blood 85:2098.
20. van Ginkel, F. W., S. M. Wahl, J. F. Kearney, M.-N. Kweon, K. Fujihashi, P. D. Burrows, H. Kiyono, and J. R. McGhee. 1999. Partial IgA-deficiency with increased Th2-type cytokines in TGF-β1 knockout mice. J. Immunol. 163:1951.
21. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693.
22. Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90:770.
23. Yaswen, L., A. B. Kulkarni, T. Fredrickson, B. Mittleman, R. Schiffman, S. Payne, G. Longenecker, E. Mozes, and S. Karlsson. 1996. Autoimmune manifestations in the transforming growth factor-β1 knockout mouse. Blood 87:1439.
24. Cazac, B. B., and J. Roes. 2000. TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13:443.
25. Holmgren, J., N. Lycke, and C. Czerkinsky. 1993. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11:1179.
26. Roberts, M., A. Bacon, R. Rappuoli, M. Pizza, I. Cropley, G. Douce, G. Dougan, M. Marinaro, J. McGhee, and S. Chatfield. 1995. A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins. Infect. Immun. 63:2100.
27. Douce, G., C. Turcotte, I. Cropley, M. Roberts, M. Pizza, M. Domenghini, R. Rappouli, and G. Dougan. 1995. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. USA 92:1644.
28. Yamamoto, S., Y. Takeda, M. Yamamoto, H. Kurazono, K. Imaoka, K. Fujihashi, M. Noda, H. Kiyono, and J. R. McGhee. 1997. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J. Exp. Med. 185:1203.
29. Rharbaoui, F., B. Drabner, S. Borsutzky, U. Winckler, M. Morr, B. Ensoli, P. F. Mühlradt, and C. A. Guzmán. 2002. The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant. Eur. J. Immunol. 32:2857.
30. Borsutzky, S., V. Fiorelli, T. Ebensen, A. Tripiciano, F. Rharbaoui, A. Scoglio, C. Link, F. Nappi, M. Morr, S. Butto, et al. 2003. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant. Eur. J. Immunol. 33:1548.
31. Mühlradt, P. F., M. Kieß, H. Meyer, R. Süßmuth, and G. Jung. 1997. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185:1951.
32. Medina, E., C. A. Guzmán, L. H. Staendner, M. P. Colombo, and P. Paglia. 1999. Salmonella vaccine carrier strains: effective delivery system to trigger anti-tumor immunity by oral route. Eur. J. Immunol. 29:693.
33. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352.
34. Kroese, F. G., W. A. Ammerlaan, and A. B. Kantor. 1993. Evidence that intestinal IgA plasma cells in μ,κ transgenic mice are derived from B-1 (Ly-1 B) cells. Int. Immunol. 5:1317.
35. de Waard, R., P. M. Dammers, J. W. Tung, A. B. Kantor, J. A. Wilshire, N. A. Bos, L. A. Herzenberg, and F. G. Kroese. 1998. Presence of germline and full-length IgA RNA transcripts among peritoneal B-1 cells. Dev. Immunol. 6:81.
36. Kim, P.-H., L. Eckmann, W. J. Lee, W. Han, and M. F. Kagnoff. 1998. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-β1. J. Immunol. 160:1198.
37. Mostov, K. E., M. Verges, and Y. Altschuler. 2000. Membrane traffic in polarized epithelial cells. Curr. Opin. Cell Biol. 12:483.
38. van Egmond, M., C. A. Damen, A. B. van Spriel, G. Vidarsson, E. van Garderen, and J. G. van de Winkel. 2001. IgA and the IgA Fc receptor. Trends Immunol. 22:205.
39. Hayakawa, K., and R. R. Hardy. 2000. Development and function of B-1 cells. Curr. Opin. Immunol. 12:346.
40. Schengrund, C. L., and N. J. Ringler. 1989. Binding of Vibrio cholera toxin and the heat-labile enterotoxin of Escherichia coli to GM1, derivatives of GM1, and nonlipid oligosaccharide polyvalent ligands. J. Biol. Chem. 264:13233.
41. van Ginkel, F. W., R. J. Jackson, Y. Yuki, and J. R. McGhee. 2000. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J. Immunol. 165:4778.
42. Sacht, G., A. Märten, U. Deiters, R. Süßmuth, G. Jung, E. Wingender, and P. F. Mühlradt. 1998. Activation of nuclear factor-κB in macrophages by mycoplasmal lipopeptides. Eur. J. Immunol. 28:4207.
43. Takeuchi, O., T. Kawai, P. F. Mühlradt, M. Morr, J. D. Radolf, A. Zychlinsky, K. Takeda, and S. Akira. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13:933.
44. Mühlradt, P. F. 2002. Immunomodulation by Mycoplasmas: artifacts, facts and active molecules. In Molecular Biology and Pathogenicity of Mycoplasmas. S. Razin and R. Herrmann, eds. Kluwer, New York, p. 445.
45. Weigt, H., P. F. Mühlradt, A. Emmendorffer, N. Krug, and A. Braun. 2003. Synthetic Mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells. Immunobiology 207:223.
46. Iwasato, T., H. Arakawa, A. Shimizu, T. Honjo, and H. Yamagishi. 1992. Biased distribution of recombination sites within S regions upon immunoglobulin class switch recombination induced by transforming growth factor β and lipopolysaccharide. J. Exp. Med. 175:1539.
47. Gonnella, P. A., Y. Chen, J. Inobe, Y. Komagata, M. Quartulli, and H. L. Weiner. 1998. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J. Immunol. 160:4708.
48. Weiner, H. L. 2001. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-β-secreting regulatory cells. Microbes Infect. 3:947.
49. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16:137.
50. Parr, M. B., G. R. Harriman, and E. L. Parr. 1998. Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice. Immunology 95:208.
51. Blanchard, T. G., S. J. Czinn, R. W. Redline, N. Sigmund, G. Harriman, and J. G. Nedrud. 1999. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice. Cell. Immunol. 191:74.
52. Zhang, Y., S. Pacheco, C. L. Acuna, K. C. Switzer, Y. Wang, X. Gilmore, G. R. Harriman, and I. N. Mbawuike. 2002. Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus. Immunology 105:286.
53. Way, S. S., A. C. Borczuk, and M. B. Goldberg. 1999. Adaptive immune response to Shigella flexneri 2a cydC in immunocompetent mice and mice lacking immunoglobulin A. Infect. Immun. 67:2001.
54. O'Neal, C. M., G. R. Harriman, and M. E. Conner. 2000. Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A. J. Virol. 74:4102.
55. Meini, A., N. M. Pillan, V. Villanacci, V. Monafo, A. G. Ugazio, and A. Plebani. 1996. Prevalence and diagnosis of celiac disease in IgA-deficient children. Ann. Allergy Asthma Immunol. 77:333.
56. Cataldo, F., V. Marino, A. Ventura, G. Bottaro, and G. R. Corazza. 1998. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study: Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and "Club del Tenue" Working Groups on Coeliac Disease. Gut 42:362.